BCAB
Price
$0.35
Change
-$0.03 (-7.89%)
Updated
Jul 25 closing price
Capitalization
20.73M
12 days until earnings call
CSPHF
Price
$0.62
Change
+$0.10 (+19.23%)
Updated
Jul 14 closing price
Capitalization
1.39B
Interact to see
Advertisement

BCAB vs CSPHF

Header iconBCAB vs CSPHF Comparison
Open Charts BCAB vs CSPHFBanner chart's image
BioAtla
Price$0.35
Change-$0.03 (-7.89%)
Volume$1.63M
Capitalization20.73M
CSTONE PHARMACEUTICALS
Price$0.62
Change+$0.10 (+19.23%)
Volume$100
Capitalization1.39B
BCAB vs CSPHF Comparison Chart in %
Loading...
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCAB vs. CSPHF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Hold and CSPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (BCAB: $0.35 vs. CSPHF: $0.62)
Brand notoriety: BCAB and CSPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 243% vs. CSPHF: 4%
Market capitalization -- BCAB: $20.73M vs. CSPHF: $1.39B
BCAB [@Biotechnology] is valued at $20.73M. CSPHF’s [@Biotechnology] market capitalization is $1.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileCSPHF’s FA Score has 0 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • CSPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, CSPHF is a better buy in the long-term than BCAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 4 TA indicator(s) are bullish while CSPHF’s TA Score has 1 bullish TA indicator(s).

  • BCAB’s TA Score: 4 bullish, 5 bearish.
  • CSPHF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, CSPHF is a better buy in the short-term than BCAB.

Price Growth

BCAB (@Biotechnology) experienced а +0.80% price change this week, while CSPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

BCAB is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSPHF($1.39B) has a higher market cap than BCAB($20.7M). CSPHF YTD gains are higher at: 176.940 vs. BCAB (-39.986).
BCABCSPHFBCAB / CSPHF
Capitalization20.7M1.39B1%
EBITDA-66.23MN/A-
Gain YTD-39.986176.940-23%
P/E RatioN/AN/A-
Revenue11MN/A-
Total Cash32.4MN/A-
Total Debt554KN/A-
TECHNICAL ANALYSIS
Technical Analysis
BCABCSPHF
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
29%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
44%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
34%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
33%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVI27.810.50
+1.83%
CVR Energy
CAPL22.180.06
+0.27%
CrossAmerica Partners LP
MFIN9.620.02
+0.21%
Medallion Financial Corp
WAB197.21-3.49
-1.74%
Wabtec
IPDN2.55-0.40
-13.56%
Professional Diversity Network Inc

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
-5.89%
AXON - BCAB
41%
Loosely correlated
+3.63%
NVO - BCAB
40%
Loosely correlated
+1.37%
KYMR - BCAB
40%
Loosely correlated
-0.13%
VCYT - BCAB
38%
Loosely correlated
+7.04%
CTMX - BCAB
38%
Loosely correlated
+0.42%
More

CSPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSPHF has been loosely correlated with DVHGF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CSPHF jumps, then DVHGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPHF
1D Price
Change %
CSPHF100%
N/A
DVHGF - CSPHF
38%
Loosely correlated
N/A
WINT - CSPHF
24%
Poorly correlated
-3.92%
BCAB - CSPHF
9%
Poorly correlated
-5.89%
SIGY - CSPHF
8%
Poorly correlated
N/A
NBTX - CSPHF
7%
Poorly correlated
+4.77%
More